Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects

Med Res Rev. 1991 Nov;11(6):617-39. doi: 10.1002/med.2610110604.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Addison Disease / drug therapy
  • Adrenal Cortex Hormones / metabolism
  • Animals
  • Brain Chemistry
  • Canrenone / metabolism
  • Canrenone / pharmacology
  • Drug Design
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Humans
  • Hyperaldosteronism / drug therapy
  • Ligands
  • Mineralocorticoid Receptor Antagonists / metabolism
  • Mineralocorticoid Receptor Antagonists / pharmacology*
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Mineralocorticoids / antagonists & inhibitors
  • Mineralocorticoids / metabolism
  • Mineralocorticoids / physiology*
  • Rats
  • Receptors, Glucocorticoid / drug effects
  • Receptors, Glucocorticoid / metabolism
  • Receptors, Mineralocorticoid
  • Receptors, Steroid / antagonists & inhibitors
  • Receptors, Steroid / drug effects*
  • Receptors, Steroid / metabolism
  • Spironolactone / analogs & derivatives
  • Spironolactone / metabolism
  • Spironolactone / pharmacology
  • Spironolactone / therapeutic use
  • Structure-Activity Relationship

Substances

  • Adrenal Cortex Hormones
  • Ligands
  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Receptors, Glucocorticoid
  • Receptors, Mineralocorticoid
  • Receptors, Steroid
  • Spironolactone
  • Canrenone